SCHEMBL20533755

SCHEMBL20533755

CC(=O)N1CCN(c2cc(N(C)c3cccc(S(C)(=O)=O)c3)n3nc(C)c(-c4ccc5c(C)nn(C)c5c4)c3n2)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 4/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
KDR P35968 1/20 0.34
DPP4 P27487 1/20 0.33
CREBBP Q92793 2/20 0.32
BRD4 O60885 1/20 0.32
HPGD P15428 3/20 0.31
ALDH1A1 P00352 3/20 0.31
NPSR1 Q6W5P4 2/20 0.31
HSD17B10 Q99714 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HTR6 P50406 2/20 0.31
GAA P10253 1/20 0.31
MEN1 O00255 1/20 0.30
HSP90AA1 P07900 1/20 0.30
KMT2A Q03164 1/20 0.30
JAK2 O60674 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20533768 0.90 PI4KB (0.35) PI4KBCYP2C9CYP2C19DPP4CREBBP
SCHEMBL20533749 0.86 PI4KB (0.34) PI4KBCYP2C9CYP2C19DPP4HPGD
SCHEMBL20533697 0.86 PI4KB (0.38) PI4KBCYP2C9CYP2C19HPGDALDH1A1
SCHEMBL20534209 0.85 PI4KB (0.34) PI4KBCYP2C9CYP2C19DPP4BRD4
SCHEMBL20533901 0.84 MAPT (0.36) PI4KBDPP4GAAJAK2JAK3
SCHEMBL20533756 0.82 PI4KB (0.54) PI4KBCYP2C9CYP2C19HPGDALDH1A1
SCHEMBL20533761 0.81 SMPD3 (0.44) HPGDALDH1A1NPSR1HSD17B10SMN1; SMN2
SCHEMBL20533888 0.80 ABCG2 (0.35) CYP2C9CYP2C19DPP4CREBBPHPGD
SCHEMBL20533769 0.72 PI4KB (0.54) PI4KBCYP2C9CYP2C19HPGDALDH1A1
SCHEMBL20533941 0.71 SMPD3 (0.49) HPGDALDH1A1HSD17B10SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180298009-A1 Fused Pyrazole Derivatives As Kinase Inhibitors UCB BIOPHARMA SPRL (BE) 2018-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180298009-A1 Fused Pyrazole Derivatives As Kinase Inhibitors PI4KA, PI4K2B, PI4KB PI4KB 3/4885CYP2C9 2274/4885CYP2C19 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.